Clinical Report: Correction of Novel Proteomic Biomarkers in Sarcoidosis

Background

Sarcoidosis is a complex granulomatous disease that can affect multiple organs, primarily the lungs. Identifying reliable biomarkers is essential for improving diagnostic accuracy and understanding the disease's pathophysiology. Recent studies have explored the role of extracellular vesicles in biomarker discovery, highlighting their potential in sarcoidosis. [Add citations here to support these claims.]

Data Highlights

No numerical or trial data is presented in the correction article, which focuses solely on author corrections.

Key Findings

• Correction of author name from 'Lea Gabby' to 'Gabrielle Lea'.
• Clarification of the author contributions statement for accuracy.
• The original findings regarding proteomic biomarkers in plasma extracellular vesicles remain unchanged.
• Extracellular vesicle proteomics is an emerging area of research in sarcoidosis.
• Previous studies have indicated the potential of EV cargo as biomarkers for sarcoidosis. [Ensure these points are directly sourced from the correction article.]

Clinical Implications

Accurate author attribution and contributions are crucial for the integrity of scientific literature.

Conclusion

The correction ensures proper acknowledgment of contributions while maintaining the integrity of the original research findings on proteomic biomarkers in sarcoidosis.

Related Resources & Content

1. Zhao R, Xi NM, Gabby L, et al., Frontiers in Immunology, 2026 -- Identification of Novel Proteomic Biomarkers in Plasma Extracellular Vesicles Associated with Sarcoidosis: A Matched Case-Control Study
2. Frontiers in Immunology — Small extracellular vesicles proteome reveals persistent inflammatory and coagulopathic dysregulation in long-COVID
3. Blood Cancer Journal — Characterizing the Bone Marrow Plasma Proteome in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance
4. Frontiers in Immunology — Single cell transcriptome signatures and cell-cell interactions associated with sarcoidosis in lung immune cell populations
5. Clinical Rheumatology — Whole genome sequencing reveals genetic variants linked to sarcoidosis in a family with a notable incidence of the disease
6. Small extracellular vesicles proteome reveals persistent inflammatory and coagulopathic dysregulation in long-COVID
7. Characterizing the Bone Marrow Plasma Proteome in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance
8. Single cell transcriptome signatures and cell-cell interactions associated with sarcoidosis in lung immune cell populations
9. ERS clinical practice guidelines on treatment of sarcoidosis
10. Frontiers | New proteomic biomarkers identified in plasma extracellular vesicles in sarcoidosis: a case-control matched study
11. aTyr Pharma Announces Topline Results from Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis | aTyr Pharma